AGX.NYSEArgan INC

Form 4: Argan CEO Exercises Options, Sells Shares for $1.6M Gain

Sentiment:

Insider Transaction Report


Argan Inc.'s CEO, Charles Edwin Collins IV, exercised stock options and simultaneously sold 7,500 shares of common stock, realizing a significant gain.

Summary

  • Charles Edwin Collins IV, Chief Executive Officer of GEMMA (a subsidiary of Argan Inc.), executed transactions involving the company's common stock.
  • On September 18, 2025, he exercised a portion of his stock option, awarded on September 12, 2018, to purchase 7,500 shares of common stock at an exercise price of $43.10 per share.
  • Concurrently, on September 18, 2025, he sold 7,500 shares of Argan Inc. common stock on the open market at a price of $257.39 per share.
  • This exercise and sale resulted in a gross profit of approximately $1,607,175 (7,500 shares * ($257.39 $43.10)).
  • Following these transactions, his direct beneficial ownership of common stock is 21,006 shares.
  • He continues to beneficially own 44,735 derivative securities (options to purchase common stock).

Sentiment

Score: 7

Explanation: The CEO realized a substantial gain from exercising options and selling shares, reflecting strong stock performance. While an insider sale reduces direct ownership, it was likely a pre-planned transaction under Rule 10b5-1, mitigating negative sentiment.

Positives

  • The high sale price of $257.39 per share indicates a strong market valuation for Argan Inc.'s stock at the time of the transaction.
  • The significant gain realized by the CEO demonstrates the substantial long-term value creation from the stock option award.

Negatives

  • The CEO's direct beneficial ownership of common stock decreased by 7,500 shares, which some investors might interpret as a reduction in insider confidence, although it was likely a pre-planned transaction.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: May observe the CEO's profit-taking, which could be viewed as a positive indicator of past performance or a neutral event if understood as a pre-planned diversification.
  • Management: The CEO realized a significant personal financial gain from long-term equity incentives.

Key Dates

DateDescription
09/12/2018Date stock option was awarded to the Reporting Person.
09/12/2019Date the stock option became exercisable.
09/18/2025Date of stock option exercise and simultaneous sale of common stock.
09/22/2025Date the Form 4 was signed by the Reporting Person.
09/12/2028Expiration date of the stock option.

Keywords

ARGAN INC, AGX, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Charles Edwin Collins IV, CEO, GEMMA

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.